Discrimination Between Invasive and In Situ Melanomas Using Clinical Close-Up Images and a De Novo Convolutional Neural Network
Background: Melanomas are often easy to recognize clinically but determining whether a melanoma is in situ (MIS) or invasive is often more challenging even with the aid of dermoscopy. Recently, convolutional neural networks (CNNs) have made significant and rapid advances within dermatology image ana...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.723914/full |
id |
doaj-16164fa4e6a4407d8f4d33b440587847 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sam Polesie Sam Polesie Martin Gillstedt Martin Gillstedt Gustav Ahlgren Hannah Ceder Hannah Ceder Johan Dahlén Gyllencreutz Julia Fougelberg Julia Fougelberg Eva Johansson Backman Eva Johansson Backman Jenna Pakka Jenna Pakka Oscar Zaar Oscar Zaar John Paoli John Paoli |
spellingShingle |
Sam Polesie Sam Polesie Martin Gillstedt Martin Gillstedt Gustav Ahlgren Hannah Ceder Hannah Ceder Johan Dahlén Gyllencreutz Julia Fougelberg Julia Fougelberg Eva Johansson Backman Eva Johansson Backman Jenna Pakka Jenna Pakka Oscar Zaar Oscar Zaar John Paoli John Paoli Discrimination Between Invasive and In Situ Melanomas Using Clinical Close-Up Images and a De Novo Convolutional Neural Network Frontiers in Medicine artificial intelligence clinical decision-making melanoma neural networks computer supervised machine learning |
author_facet |
Sam Polesie Sam Polesie Martin Gillstedt Martin Gillstedt Gustav Ahlgren Hannah Ceder Hannah Ceder Johan Dahlén Gyllencreutz Julia Fougelberg Julia Fougelberg Eva Johansson Backman Eva Johansson Backman Jenna Pakka Jenna Pakka Oscar Zaar Oscar Zaar John Paoli John Paoli |
author_sort |
Sam Polesie |
title |
Discrimination Between Invasive and In Situ Melanomas Using Clinical Close-Up Images and a De Novo Convolutional Neural Network |
title_short |
Discrimination Between Invasive and In Situ Melanomas Using Clinical Close-Up Images and a De Novo Convolutional Neural Network |
title_full |
Discrimination Between Invasive and In Situ Melanomas Using Clinical Close-Up Images and a De Novo Convolutional Neural Network |
title_fullStr |
Discrimination Between Invasive and In Situ Melanomas Using Clinical Close-Up Images and a De Novo Convolutional Neural Network |
title_full_unstemmed |
Discrimination Between Invasive and In Situ Melanomas Using Clinical Close-Up Images and a De Novo Convolutional Neural Network |
title_sort |
discrimination between invasive and in situ melanomas using clinical close-up images and a de novo convolutional neural network |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Medicine |
issn |
2296-858X |
publishDate |
2021-09-01 |
description |
Background: Melanomas are often easy to recognize clinically but determining whether a melanoma is in situ (MIS) or invasive is often more challenging even with the aid of dermoscopy. Recently, convolutional neural networks (CNNs) have made significant and rapid advances within dermatology image analysis. The aims of this investigation were to create a de novo CNN for differentiating between MIS and invasive melanomas based on clinical close-up images and to compare its performance on a test set to seven dermatologists.Methods: A retrospective study including clinical images of MIS and invasive melanomas obtained from our department during a five-year time period (2016–2020) was conducted. Overall, 1,551 images [819 MIS (52.8%) and 732 invasive melanomas (47.2%)] were available. The images were randomized into three groups: training set (n = 1,051), validation set (n = 200), and test set (n = 300). A de novo CNN model with seven convolutional layers and a single dense layer was developed.Results: The area under the curve was 0.72 for the CNN (95% CI 0.66–0.78) and 0.81 for dermatologists (95% CI 0.76–0.86) (P < 0.001). The CNN correctly classified 208 out of 300 lesions (69.3%) whereas the corresponding number for dermatologists was 216 (72.0%). When comparing the CNN performance to each individual reader, three dermatologists significantly outperformed the CNN.Conclusions: For this classification problem, the CNN was outperformed by the dermatologist. However, since the algorithm was only trained and validated on 1,251 images, future refinement and development could make it useful for dermatologists in a real-world setting. |
topic |
artificial intelligence clinical decision-making melanoma neural networks computer supervised machine learning |
url |
https://www.frontiersin.org/articles/10.3389/fmed.2021.723914/full |
work_keys_str_mv |
AT sampolesie discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork AT sampolesie discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork AT martingillstedt discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork AT martingillstedt discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork AT gustavahlgren discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork AT hannahceder discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork AT hannahceder discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork AT johandahlengyllencreutz discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork AT juliafougelberg discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork AT juliafougelberg discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork AT evajohanssonbackman discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork AT evajohanssonbackman discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork AT jennapakka discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork AT jennapakka discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork AT oscarzaar discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork AT oscarzaar discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork AT johnpaoli discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork AT johnpaoli discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork |
_version_ |
1717380107722555392 |
spelling |
doaj-16164fa4e6a4407d8f4d33b4405878472021-09-14T05:00:12ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2021-09-01810.3389/fmed.2021.723914723914Discrimination Between Invasive and In Situ Melanomas Using Clinical Close-Up Images and a De Novo Convolutional Neural NetworkSam Polesie0Sam Polesie1Martin Gillstedt2Martin Gillstedt3Gustav Ahlgren4Hannah Ceder5Hannah Ceder6Johan Dahlén Gyllencreutz7Julia Fougelberg8Julia Fougelberg9Eva Johansson Backman10Eva Johansson Backman11Jenna Pakka12Jenna Pakka13Oscar Zaar14Oscar Zaar15John Paoli16John Paoli17Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenDepartment of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenDepartment of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenDepartment of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenDepartment of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenDepartment of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenDepartment of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenDepartment of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenBackground: Melanomas are often easy to recognize clinically but determining whether a melanoma is in situ (MIS) or invasive is often more challenging even with the aid of dermoscopy. Recently, convolutional neural networks (CNNs) have made significant and rapid advances within dermatology image analysis. The aims of this investigation were to create a de novo CNN for differentiating between MIS and invasive melanomas based on clinical close-up images and to compare its performance on a test set to seven dermatologists.Methods: A retrospective study including clinical images of MIS and invasive melanomas obtained from our department during a five-year time period (2016–2020) was conducted. Overall, 1,551 images [819 MIS (52.8%) and 732 invasive melanomas (47.2%)] were available. The images were randomized into three groups: training set (n = 1,051), validation set (n = 200), and test set (n = 300). A de novo CNN model with seven convolutional layers and a single dense layer was developed.Results: The area under the curve was 0.72 for the CNN (95% CI 0.66–0.78) and 0.81 for dermatologists (95% CI 0.76–0.86) (P < 0.001). The CNN correctly classified 208 out of 300 lesions (69.3%) whereas the corresponding number for dermatologists was 216 (72.0%). When comparing the CNN performance to each individual reader, three dermatologists significantly outperformed the CNN.Conclusions: For this classification problem, the CNN was outperformed by the dermatologist. However, since the algorithm was only trained and validated on 1,251 images, future refinement and development could make it useful for dermatologists in a real-world setting.https://www.frontiersin.org/articles/10.3389/fmed.2021.723914/fullartificial intelligenceclinical decision-makingmelanomaneural networkscomputersupervised machine learning |